CVB homepage

Vascudyne off-the-shelf bioengineered blood vessel for CABG two-year results presented at EACTS 2026.

The experimental technology could help clinicians perform CABG procedures without needing to harvest vessels from the patient.

Shockwave Medical, a Johnson & Johnson MedTech company, has officially launched its Shockwave E8 Peripheral IVL Catheter in the United States. Shockwave’s E8 catheter was designed specifically to treat patients with calcified femoropopliteal and below-the-knee (BTK) peripheral artery disease (PAD), including those diagnosed with complex chronic limb-threatening ischemia (CLTI).

Atherectomy is still the go-to treatment option for many clinicians, but peripheral IVL appears to be gaining momentum as time goes on. 

Cara Santillo explains how new CPT codes are expanding reimbursement CCTA AI. #Heartflow #SCCT #YesCCT

New codes for these technologies have made a world of difference for clinicians. Reimbursement for the use of AI is an area where cardiology is far ahead of most other healthcare specialties.

According to the U.S. government, Asante Health System and one of its surgeons knowingly submitted false claims to Medicare, Medicaid and TRICARE for more than six years. Heart surgery surgeons.

According to Newsweek, 13 of the top 20 hospitals for cardiac surgery in the entire world are located in the United States. The list includes 150 hospitals in total. 

Michael Coords, MD, FSCCT, medical director of cardiovascular imaging at RadNet, explains what the new Maryland law requires when when breast artery calcifications are found in mammograms that indicate the patient may have higher risk of cardiovascular disease.

The law reflects growing interest in using existing imaging studies to identify cardiovascular disease risk without requiring additional scans, radiation exposure or costs. 

Cleerly mobile CCTA scans

Cleerly and Clear Heart and Lung Imaging partnered to drive a cardiac-capable mobile CT scanner across Arizona, Louisiana, Georgia and Florida. Their goals were to evaluate patients in underserved parts of the United States and collect data for an ongoing clinical trial.

Innovation at work

For hospitals, health systems and physician groups, effective cardiovascular strategic planning is the foundation for better cardiovascular care delivery, stronger service line performance and sustainable program growth. This article offers a practical approach for cardiovascular leaders who want a service line strategy that is more than a document.

Sponsored by MedAxiom